Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
40.3M
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
16.9M
-
Shares change
-
-491K
-
Total reported value, excl. options
-
$180M
-
Value change
-
-$5.75M
-
Put/Call ratio
-
2.83
-
Number of buys
-
28
-
Number of sells
-
-19
-
Price
-
$10.64
Significant Holders of TELA Bio, Inc. - Common Stock (TELA) as of Q1 2023
60 filings reported holding TELA - TELA Bio, Inc. - Common Stock as of Q1 2023.
TELA Bio, Inc. - Common Stock (TELA) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.9M shares
of 40.3M outstanding shares and own 42.05% of the company stock.
Largest 10 shareholders include Essex Woodlands Management, Inc. (4.11M shares), ORBIMED ADVISORS LLC (3.03M shares), Opaleye Management Inc. (2.07M shares), AIGH Capital Management LLC (1.65M shares), NEXT CENTURY GROWTH INVESTORS LLC (778K shares), Velan Capital Investment Management LP (746K shares), VANGUARD GROUP INC (710K shares), Pentwater Capital Management LP (490K shares), Worth Venture Partners, LLC (410K shares), and PURA VIDA INVESTMENTS, LLC (372K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.